"Parkson" Baimetrino Fress drug releases coronary stent system
Taiwan·Risk Class 3·BIOSENSORS EUROPE SA;; BIOSENSORS INTERVENTIONAL TECHNOLOGIES PTE LTD.·Registered Sep 12, 2014 – Sep 12, 2024Expired- Analysis ID
- 4fcd4655a6d1d2edc2ff60a23857ae18
- Customs Code
- DHA05602655807
- Manufacturer Country
- Switzerland;;Singapore
- Authorized Representative
- IDS MEDICAL SYSTEMS (HONG KONG) COMPANY LIMITED, TAIWAN BRANCH (HONG KONG)
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- E Cardiovascular Medicine Science
- Product Type (Level 2)
- E.0001 Cardiovascular stents
- Import Information
- import
- Registration Date
- Sep 12, 2014
- Expiry Date
- Sep 12, 2024
Access comprehensive regulatory information for "Parkson" Baimetrino Fress drug releases coronary stent system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 4fcd4655a6d1d2edc2ff60a23857ae18 and manufactured by BIOSENSORS EUROPE SA;; BIOSENSORS INTERVENTIONAL TECHNOLOGIES PTE LTD.. The authorized representative in Taiwan is IDS MEDICAL SYSTEMS (HONG KONG) COMPANY LIMITED, TAIWAN BRANCH (HONG KONG).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.